Cross‐presenting dendritic cells are required for control of Leishmania major infection

Leishmania major infection induces self‐healing cutaneous lesions in C57BL/6 mice. Both IL‐12 and IFN‐γ are essential for the control of infection. We infected Jun dimerization protein p21SNFT (Batf3−/−) mice (C57BL/6 background) that lack the major IL‐12 producing and cross‐presenting CD8α+ and CD103+ DC subsets. Batf3−/− mice displayed enhanced susceptibility with larger lesions and higher parasite burden. Additionally, cells from draining lymph nodes of infected Batf3−/− mice secreted less IFN‐γ, but more Th2‐ and Th17‐type cytokines, mirrored by increased serum IgE and Leishmania‐specific immunoglobulin 1 (Th2 indicating). Importantly, CD8α+ DCs isolated from lymph nodes of L. major‐infected mice induced significantly more IFN‐γ secretion by L. major‐stimulated immune T cells than CD103+ DCs. We next developed CD11c‐diptheria toxin receptor: Batf3−/− mixed bone marrow chimeras to determine when the DCs are important for the control of infection. Mice depleted of Batf‐3‐dependent DCs from day 17 or wild‐type mice depleted of cross‐presenting DCs from 17–19 days after infection maintained significantly larger lesions similar to mice whose Batf‐3‐dependent DCs were depleted from the onset of infection. Thus, we have identified a crucial role for Batf‐3‐dependent DCs in protection against L. major.

[1]  M. Olivier,et al.  Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. , 2013, Cell host & microbe.

[2]  K. Murphy,et al.  Specificity through cooperation: BATF–IRF interactions control immune-regulatory networks , 2013, Nature Reviews Immunology.

[3]  Werner Müller,et al.  T Cell-Derived IL-10 Determines Leishmaniasis Disease Outcome and Is Suppressed by a Dendritic Cell Based Vaccine , 2013, PLoS pathogens.

[4]  P. Scott,et al.  IL-17 Mediates Immunopathology in the Absence of IL-10 Following Leishmania major Infection , 2013, PLoS pathogens.

[5]  S. Nutt,et al.  CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. , 2013, Blood.

[6]  Michael S. Behnke,et al.  Compensatory dendritic cell development mediated by BATF-IRF interactions , 2012, Nature.

[7]  K. Murphy,et al.  DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. , 2012, Blood.

[8]  F. Tacchini-Cottier,et al.  Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model , 2012, Front. Immun..

[9]  A. Debrabant,et al.  Efficient Capture of Infected Neutrophils by Dendritic Cells in the Skin Inhibits the Early Anti-Leishmania Response , 2012, PLoS pathogens.

[10]  Mark J. Miller,et al.  CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. , 2011, Immunity.

[11]  Michelle M. Sandau,et al.  CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. , 2011, Immunity.

[12]  Clare L. Bennett,et al.  Langerhans cells are negative regulators of the anti-Leishmania response , 2011, The Journal of experimental medicine.

[13]  W. Heath,et al.  The CD8+ dendritic cell subset , 2010, Immunological reviews.

[14]  F. Tacchini-Cottier,et al.  Neutrophil-Derived CCL3 Is Essential for the Rapid Recruitment of Dendritic Cells to the Site of Leishmania major Inoculation in Resistant Mice , 2010, PLoS pathogens.

[15]  F. Ginhoux,et al.  The origin and development of nonlymphoid tissue CD103+ DCs , 2009, The Journal of experimental medicine.

[16]  A. Brooks,et al.  Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells , 2009, Nature Immunology.

[17]  Y. Iwakura,et al.  IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice1 , 2009, The Journal of Immunology.

[18]  M. Ritter,et al.  CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self , 2009, Molecular immunology.

[19]  B. Malissen,et al.  Priming of CD8+ and CD4+ T Cells in Experimental Leishmaniasis Is Initiated by Different Dendritic Cell Subtypes1 , 2009, The Journal of Immunology.

[20]  E. Unanue,et al.  Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.

[21]  L. Ng,et al.  Migratory Dermal Dendritic Cells Act as Rapid Sensors of Protozoan Parasites , 2008, PLoS pathogens.

[22]  Li Wu,et al.  Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset , 2008, Proceedings of the National Academy of Sciences.

[23]  B. León,et al.  Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. , 2007, Immunity.

[24]  Sylvie Bertholet,et al.  Leishmania Antigens Are Presented to CD8+ T Cells by a Transporter Associated with Antigen Processing-Independent Pathway In Vitro and In Vivo , 2006, The Journal of Immunology.

[25]  N. Glaichenhaus,et al.  Lymph Node Resident Rather Than Skin-Derived Dendritic Cells Initiate Specific T Cell Responses after Leishmania major Infection , 2006, The Journal of Immunology.

[26]  Y. Belkaid,et al.  A Role for CD103 in the Retention of CD4+CD25+ Treg and Control of Leishmania major Infection1 , 2005, The Journal of Immunology.

[27]  R. Spinelli,et al.  Dendritic cells in Leishmania infection. , 2004, Microbes and infection.

[28]  Mark C Udey,et al.  Requirements for Th1-dependent immunity against infection with Leishmania major. , 2004, Microbes and infection.

[29]  H. Körner,et al.  CD8α‐ and Langerin‐negative dendritic cells, but not Langerhans cells, act as principal antigen‐presenting cells in leishmaniasis , 2004, European journal of immunology.

[30]  P. Scott,et al.  MHC Class II Expression Restricted to CD8α+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major , 2004, The Journal of experimental medicine.

[31]  T. Kamradt,et al.  Two waves of antigen‐containing dendritic cells in vivo in experimental Leishmania major infection , 2004, European journal of immunology.

[32]  W. Paul,et al.  The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility to Leishmania major1 , 2003, The Journal of Immunology.

[33]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[34]  D. Sacks,et al.  The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.

[35]  Scott N. Mueller,et al.  The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens , 2002, The Journal of experimental medicine.

[36]  H. Hochrein,et al.  Hierarchy of Susceptibility of Dendritic Cell Subsets to Infection by Leishmania major: Inverse Relationship to Interleukin-12 Production , 2002, Infection and Immunity.

[37]  P. Scott,et al.  The Role of IL-12 in Maintaining Resistance to Leishmania major1 , 2002, The Journal of Immunology.

[38]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[39]  Y. Liu,et al.  Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.

[40]  N. Glaichenhaus,et al.  The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Scott,et al.  IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection1 , 2000, The Journal of Immunology.

[42]  J. Blackwell,et al.  IL-13 Is a Susceptibility Factor for Leishmania major Infection , 2000, The Journal of Immunology.

[43]  F. Mattner,et al.  Interleukin-12 is indispensable for protective immunity against Leishmania major , 1997, Infection and immunity.

[44]  P. Scott,et al.  The Role of IL‐12 in Regulation of T Helper Cell Subsets in Vivo , 1996, Annals of the New York Academy of Sciences.

[45]  M. Röllinghoff,et al.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.

[46]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[47]  B. F. Hall,et al.  CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. , 1989, Journal of immunology.

[48]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[49]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[50]  J. Louis,et al.  T-cell responses and immunity to experimental infection with leishmania major. , 1989, Annual review of immunology.